Literature DB >> 19212181

Metabolic and neuroendocrine consequences of a duodenal-jejunal bypass in rats on a choice diet.

James P Warne1, Benjamin E Padilla, Hart F Horneman, Abigail B Ginsberg, Norman C Pecoraro, Susan F Akana, Mary F Dallman.   

Abstract

OBJECTIVE: We sought to examine insulin-sensitive food intake behavior and neuroendocrine and metabolic variables of rats that had undergone a duodenal-jejunal bypass (DJB). SUMMARY OF BACKGROUND DATA: A DJB that circumvents the duodenum and proximal jejunum while leaving the stomach unperturbed rapidly improves insulin sensitivity in type 2 diabetic rats. This segment of proximal small intestine is innervated by the gastroduodenal branch of the vagus nerve, the transection of which influences food intake choices in streptozotocin-diabetic rats.
METHODS: Rats were first placed on a choice of chow and lard for 7 days and additionally provided with an enriched liquid diet for another 7 days before surgery and were allowed only the liquid diet for 7 days after either a sham or DJB operation.
RESULTS: After surgery, DJB-operated rats initially consumed less than the sham-operated counterparts. When the rats were subsequently provided with the choice of chow and lard for 7 days, there were no differences in intake between the DJB and sham-operated groups. Similarly, the majority of metabolic and neuroendocrine variables measured were unchanged. However, DJB-operated rats exhibited greater mesenteric white adipose tissue weight, fecal output, arcuate nucleus neuropeptide Y mRNA expression, plasma corticosterone, and glucagon levels together with reduced plasma leptin concentrations.
CONCLUSIONS: DJB surgery does not produce significant differences in food intake choices after a period of recovery; however, there are enduring metabolic and neuroendocrine changes, which are collectively important to understanding the beneficial outcomes of the operation.

Entities:  

Mesh:

Year:  2009        PMID: 19212181     DOI: 10.1097/SLA.0b013e3181961d5d

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  7 in total

Review 1.  Recent advances in clinical practice challenges and opportunities in the management of obesity.

Authors:  Andres Acosta; Barham K Abu Dayyeh; John D Port; Michael Camilleri
Journal:  Gut       Date:  2014-01-08       Impact factor: 23.059

Review 2.  Obesity surgery and gut-brain communication.

Authors:  Hans-Rudolf Berthoud; Andrew C Shin; Huiyuan Zheng
Journal:  Physiol Behav       Date:  2011-02-24

Review 3.  Appetite and body weight regulation after bariatric surgery.

Authors:  H Münzberg; A Laque; S Yu; K Rezai-Zadeh; H-R Berthoud
Journal:  Obes Rev       Date:  2015-02       Impact factor: 9.213

Review 4.  Obesity surgery: happy with less or eternally hungry?

Authors:  Andrew C Shin; Hans-Rudolf Berthoud
Journal:  Trends Endocrinol Metab       Date:  2013-01-11       Impact factor: 12.015

5.  Reversible hyperphagia and obesity in rats with gastric bypass by central MC3/4R blockade.

Authors:  Michael B Mumphrey; Zheng Hao; R Leigh Townsend; Laurel M Patterson; Christopher D Morrison; Heike Münzberg; Nicholas Stylopoulos; Jianping Ye; Hans-Rudolf Berthoud
Journal:  Obesity (Silver Spring)       Date:  2014-05-02       Impact factor: 5.002

6.  Global transcriptome analysis of rat hypothalamic arcuate nucleus demonstrates reversal of hypothalamic gliosis following surgically and diet induced weight loss.

Authors:  Pernille Barkholt; Kristoffer T G Rigbolt; Mechthilde Falkenhahn; Thomas Hübschle; Uwe Schwahn; Maria Luisa Fernandez-Cachon; Thorsten Schmidt; Stefan Theis; Henrik H Hansen; Anders Hay-Schmidt; Philip J Pedersen; Niels Vrang; Jacob Jelsing
Journal:  Sci Rep       Date:  2019-11-06       Impact factor: 4.379

7.  Alterations in hypothalamic gene expression following Roux-en-Y gastric bypass.

Authors:  Pernille Barkholt; Philip J Pedersen; Anders Hay-Schmidt; Jacob Jelsing; Henrik H Hansen; Niels Vrang
Journal:  Mol Metab       Date:  2016-01-25       Impact factor: 7.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.